UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

Molecular cancer research, 2017-01, Vol.15 (1), p.78-92

2017

Volltextzugriff (PDF)

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2477-2499

2020

Volltextzugriff (PDF)

The Role of MicroRNAs in Ovarian Cancer

BioMed research international, 2014-01, Vol.2014, p.249393-11

2014

Volltextzugriff (PDF)

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

Molecular cancer, 2016-06, Vol.15 (1), p.48-48, Article 48

2016

Volltextzugriff (PDF)

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

BMC cancer, 2018-11, Vol.18 (1), p.1065-1065, Article 1065

2018

Volltextzugriff (PDF)

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

PloS one, 2015-02, Vol.10 (2), p.e0118080-e0118080

2015

Volltextzugriff (PDF)

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Scientific reports, 2015-12, Vol.5 (1), p.18217-18217, Article 18217

2015

Volltextzugriff (PDF)

Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy

International journal of clinical oncology, 2022-03, Vol.27 (3), p.602-608

2022

Volltextzugriff (PDF)

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

Cancers, 2017-07, Vol.9 (7), p.83

2017

Volltextzugriff (PDF)

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2017-08, Vol.114 (35), p.E7301-E7310

2017

Volltextzugriff (PDF)

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Cancers, 2019-08, Vol.11 (8), p.1147

2019

Volltextzugriff (PDF)

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

Cells (Basel, Switzerland), 2020-03, Vol.9 (4), p.814

2020

Volltextzugriff (PDF)

Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1

Biochemical and biophysical research communications, 2021-05, Vol.552, p.120-127

2021

Volltextzugriff (PDF)

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

Clinical cancer research, 2018-08, Vol.24 (16), p.4018-4029

2018

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Journal of ovarian research, 2018-09, Vol.11 (1), p.81-81, Article 81

2018

Volltextzugriff (PDF)

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

Cancers, 2022-07, Vol.14 (15), p.3580

2022

Volltextzugriff (PDF)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

Oncotarget, 2015-05, Vol.6 (13), p.11342-11356

2015

Volltextzugriff (PDF)

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

The American journal of pathology, 2013-05, Vol.182 (5), p.1876-1889

2013

Volltextzugriff (PDF)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Scientific reports, 2020-10, Vol.10 (1), p.16755, Article 16755

2020

Volltextzugriff (PDF)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

PloS one, 2016-03, Vol.11 (3), p.e0151050-e0151050

2016

Volltextzugriff (PDF)

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Oncotarget, 2018-11, Vol.9 (91), p.36317-36330

2018

Volltextzugriff (PDF)

Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment

Cancers, 2024-04, Vol.16 (8), p.1482

2024

Volltextzugriff (PDF)

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5413-5424

2021

Volltextzugriff (PDF)

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Clinical cancer research, 2011-06, Vol.17 (12), p.4042-4051

2011

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(219)
Japanisch
(78)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

The Role of MicroRNAs in Ovarian Cancer

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy

Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment

Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Suchergebnisse filtern